The 'valvulo-metabolic' risk in calcific aortic valve disease.
Calcific aortic stenosis (AS) has been considered a degenerative and unmodifiable process resulting from aging and 'wear and tear' of the aortic valve. Over the past decade, studies in the field of epidemiology, molecular biology and lipid metabolism have highlighted similarities between vascular atherosclerosis and calcific AS. In particular, work from the Quebec Heart Institute and from that of others has documented evidence of valvular infiltration by oxidized low-density lipoproteins and the presence of inflammatory cells, along with important tissue remodelling in valves explanted from patients with AS. Recent studies have also emphasized the role of visceral obesity in the development and progression of AS. In addition, visceral obesity, with its attendant metabolic complications, commonly referred to as the metabolic syndrome, has been associated with degenerative changes in bioprosthetic heart valves. The purpose of the present review is to introduce the concept of 'valvulo-metabolic risk' and to provide an update on the recent and important discoveries regarding the pathogenesis of heart valve diseases in relation to obesity, and to discuss how these novel mechanisms might translate into clinical practice.
Mathieu
Patrick
P
Laboratoire d'Etudes Moléculaires des Valvulopathies, Groupe de Recherche en Valvulopathies, Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Québec, Quebec. patrick.mathieu@chg.ulaval.ca
Després
J P
JP
Pibarot
P
P
D001021:Aortic Valve / Q000473:pathology*; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000473:pathology*; D001705:Bioprosthesis; D002114:Calcinosis / Q000150:complications / Q000473:pathology*; D050171:Dyslipidemias / Q000150:complications / Q000503:physiopathology; D006349:Heart Valve Diseases / Q000150:complications / Q000473:pathology*; D006350:Heart Valve Prosthesis; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000503:physiopathology; D050152:Intra-Abdominal Fat; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology; D009765:Obesity / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D012307:Risk Factors